Yatharth Hospital Issues Corrigendum for Rs 3,150 Crore Preferential Share Issue

Issue Price: Rs 985.17 per unit | Total Proposed Capital Raise: Approx Rs 3,150 crore

Reader Takeaway: Procedural transparency improves with CRISIL monitoring, supporting long-term network expansion despite potential equity dilution risks.

What just happened

Yatharth Hospital & Trauma Care Services has issued a formal corrigendum ahead of its Extraordinary General Meeting (EGM) scheduled for October 15, 2026. The filing provides specific clarifications regarding the previously announced preferential issue of equity shares and convertible warrants. The company confirmed an issue price of Rs 985.17 per unit, calculated as the highest value among recent volume-weighted averages and independent fair valuation.

Why this matters

The preferential issue aims to raise significant capital for hospital network expansion and infrastructure development. The company is issuing up to 1.30 crore equity shares and 1.89 crore warrants. By appointing CRISIL Ratings as a monitoring agency for this raise—which exceeds Rs 100 crore—the company is enhancing corporate governance and providing investors with a quarterly window into how these funds are deployed across its hospital assets and general corporate requirements.

The backstory

The company previously announced its intent to raise funds to bolster its healthcare infrastructure. The current filing acts as a regulatory clean-up to ensure compliance with National Stock Exchange requirements. It explicitly details the utilization of funds, earmarking over Rs 2,300 crore for expansion and infrastructure, with the remainder dedicated to general corporate purposes. Warrants carry a tenure of 18 months, providing the company with a staggered capital inflow mechanism.

Risks to watch

Investors should consider the impact of equity dilution resulting from the issuance of over 1.30 crore shares. Additionally, while the monitoring agency provides oversight, the actual execution and profitability of the planned hospital expansions remain dependent on operational efficiency and market demand in the target regions.

What to track next

Watch for the EGM proceedings on October 15, 2026, and subsequent quarterly reports from CRISIL Ratings regarding the deployment of the raised capital.